Publication at Second Faculty of Medicine |
2011
Abstract
Three cases of patients with severe chronic plaque psoriasis in whom classical systemic therapy failed or was discontinued due to side effects are described. After three months of ustekinumab administration more than a year-long remission was achieved in all cases.
The therapy is tolerated well, followed laboratory tests are within normal range. Authors draw attention to the new biological agent in the treatment of severe plaque psoriasis.